Acuren (TIC) likely needs to outgrow its end market to sustain a mid-single-digit organic growth over time, UBS Securities said in a Friday note as it initiated coverage on the company with a neutral rating and a $13 price target.
A longer public company track record is needed to build conviction, the firm said.
UBS said Acuren could achieve outgrowth through competitive positioning, a focus on recurring revenue, and leadership in rope access, but a longer track record is needed to build confidence in sustainable mid-single-digit organic growth.
The firm forecasts Acuren to grow organic revenue by 4 to 5% in 2025 and 2026 but noted that sustaining this level would likely require the company to gain market share.
The firm noted that Acuren, a provider of nondestructive testing and rope access services for oil and gas and other industrial markets, is looking to establish a steady operating model in historically cyclical end markets.
UBS said improved oil and gas fundamentals, strong execution, and return-accretive capital deployment could lead to a more positive view, while a weaker demand backdrop or execution challenges could have the opposite effect.
Acuren shares were down over 2% in recent Friday trading.
Price: 11.47, Change: -0.25, Percent Change: -2.13
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.